Asian Industry Groups Push For Universal Care, E-Labeling, Flexible Supply Chain
Joint Assessment Progressing
An annual meeting of Asian pharma industry groups in Tokyo recognized the need for faster joint regulatory allowance for second suppliers to stabilize the supply chain, drive e-labeling for patients and expand universal healthcare to better cover expensive therapeutics.
